Richard Barry
CEO, President at Cassava Sciences Inc (FLNA); CEO, President at Filana Therapeutics, Inc. (FLNA)
Purchase track record
Below average. Based on 2 purchases with a full 90 days of price history.
15
Avg. 90-day return-22.3%
vs. S&P 500-26.2%
Beat the market0%
Paper profit on buys−$461K
Total bought / sold$972K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 1SEC | FLNAFilana Therapeutics, Inc. | Buy | 206,8131,237,964 held (+20%) | $0.90 | $186K | -8.9% |
| Oct 1SEC | FLNAFilana Therapeutics, Inc. | Buy | 100,0001,337,964 held (+8%) | $0.92 | $92K | -10.9% |
| Sep 30SEC | FLNAFilana Therapeutics, Inc. | Buy | 93,0911,031,151 held (+10%) | $0.84 | $78K | -2.4% |
| Nov 24SEC | FLNACassava Sciences Inc | Buy | 150,000938,060 held (+19%) | $2.76 | $414K | -70.3% |
| Nov 20SEC | FLNACassava Sciences Inc | Buy | 73,385788,060 held (+10%) | $2.75 | $202K | -70.2% |
- Buy
CEO, President Richard Barry bought $186K of FLNA at $0.90 — raises the stake by 20%.
- Buy
CEO, President Richard Barry bought $414K of FLNA at $2.76 — largest purchase by this insider in our records.
- Buy
CEO, President Richard Barry bought $202K of FLNA at $2.75 — first open-market purchase in our records.